ArticleHeliyon2024
Biodiesel production through transesterification of waste Pistacia- Terebinthus Oil by pharmaceutical waste as a heterogeneous catalyst: A sustainable solution for reducing external costs.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multifunctional Valorisation of Pistachio (International journal of molecular sciences · 2026Review
- Progress and Challenges in the Process of Using Solid Waste as a Catalyst for Biodiesel Synthesis.Molecules (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A catalyst from the pharmaceutical waste of calcium and magnesium tablets was synthesized for biodiesel production from waste Pistacia-Terebinthus (PT) oil with the aim of creating added value and presenting a new approach for the management of such wastes. For this purpose, magnesium and calcium tablet wastes with a mass ratio of 70:30 (wt%) were calcined. The catalyst was investigated by several methods, such as thermal gravimetric analysis, X-ray diffraction, Fourier transform infrared spectroscopy, field emission scanning electron microscopy, Brunauer-Emmett-Teller analysis, X-ray photoelectron spectroscopy, and CHNS/O elemental analysis. The high specific surface area of the catalyst confirms that the utilized synthesis method resulted in the formation of a high number of active sites in its structure, which allows it to function as a suitable catalyst for this reaction. Furthermore, the impact of effective parameters on the treansestrification reaction was optimized and investigated by designing the experiments and applying the RSM method. The maximum mass yield of 96 % was obtained in optimal conditions (temperature of 70 °C, catalyst loading of 4.498 wt%, methanol:oil ratio of 1.968 (vol:vol), and reaction time of 120 min). The reusability of the catalyst was investigated in four successive cycles. The mass yield of the last test declined from 96 % to 71.4 %. Gas chromatography-mass spectrometry analysis of the produced biofuel revealed that it comprises 91.37 % methyl ester compounds (64.28 % 12-Octadecenoic Acid, Methyl Ester). To evaluate the external costs of biofuel (B100) and compare it with diesel, combustion simulation was done with Diesel-RK software, which showed that its external costs were 0.05388 (€/Lit fuel) less than those of diesel.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.